| 摘要 |
FIELD: medicine, oncology, chemical-pharmaceutical industry, pharmacy. ^ SUBSTANCE: invention can be used in clinical practice for treatment of oncological diseases. Invention proposes an allogenic preparation from human placenta based on nucleoproteids complex fragmented to 200-2000 nucleotide pairs and comprising, wt.-%: DNA 60-80; nuclear matrix proteins, 20-40. The advantage of invention involves the presence of complex pharmaceutical activity and provides antitumor, antitoxic and radioprotecting effect of the preparation. ^ EFFECT: valuable medicinal properties of preparation. ^ 3 cl, 2 tbl, 1 dwg, 3 ex |
